October 9, 2018 / 11:37 PM / in 2 months

U.S. Supreme Court declines antitrust case against Pfizer over Lipitor

The U.S. Supreme Court on Tuesday declined to review the dismissal of a lawsuit involving a group of California pharmacists who allege Pfizer Inc conspired with Ranbaxy Laboratories Ltd to delay sales of generic versions of its cholesterol drug Lipitor.

The justices let stand a ruling by the 3rd U.S. Circuit Court of Appeals in Philadelphia dismissing the pharmacists’ case on the grounds that the lawsuit failed to allege a violation of California antitrust law.

To read the full story on Westlaw Practitioner Insights, click here: bit.ly/2C41uns

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below